Systematic Review of Case Reports of Bacillus Calmette-Guerin Vascular Infections

被引:3
|
作者
Ho, Kelvin Kam Fai [1 ,2 ]
Lal, Vidushi [2 ]
Hagley, Daniel [1 ]
Bingley, John [1 ]
机构
[1] Mater Hosp Brisbane, Dept Vasc Surg, South Brisbane, Qld, Australia
[2] Sunshine Coast Univ Hosp, Dept Vasc Surg, Birtinya, Qld, Australia
关键词
MYCOTIC AORTIC-ANEURYSM; INTRAVESICAL BCG THERAPY; MYCOBACTERIUM-BOVIS; BLADDER-CANCER; PSOAS ABSCESS; ABDOMINAL-AORTA; VERTEBRAL OSTEOMYELITIS; COMPLICATION; IMMUNOTHERAPY; INSTILLATION;
D O I
10.1016/j.avsg.2022.01.027
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Bacillus Calmette-Guerin (BCG) is a live attenuated strain of Mycobacterium bovis that has been used as immunotherapy against several malignancies. In particular, intravesical instillation of BCG has become a well-accepted adjuvant treatment for bladder cancer. BCG vascular infections are a rare complication of BCG therapy. Many aspects of these infections, including the presentations, risk factors, and treatment strategies, are poorly understood. Through a systematic review of the existing literature, we aimed to identify potential associations between this condition and patient characteristics, presentations, its treatments, and outcomes. Methods: We searched the PubMed, MEDLINE, and Embase databases for cases of BCG vascular infections from inception to June 2021. English-language reports of BCG vascular infections were included. Results: A total of 74 cases of BCG vascular infections were included. Seventy-three (99%) cases were male patients, all of whom were exposed to BCG through bladder instillation. Fifty (68%) cases were diagnosed more than 12 months after exposure to BCG. Twentysix (35%) cases presented with arterial rupture at the time of diagnosis. Concurrent BCG infections in nonvascular locations were present in 37 (50%) cases. The most common locations of BCG vascular infection were the abdominal aorta (57%), prosthetic grafts (15%), and thoracic aorta (12%). The most common treatment for BCG infection was open repair with synthetic graft in situ replacement for the abdominal aorta and endovascular repair for the thoracic aorta. The 30-day mortality, among the 59 cases where these data were reported, was 10%. Conclusions: We observed that many aspects of BCG vascular infections are similar to other forms of vascular infections. The high incidence of rupture or fistulation and the propensity toward abdominal aortic involvement and its prognosis are similar to those described in other vascular infections. However, our study also highlights 2 idiosyncratic features of BCG vascular infections: association with male sex and concurrent musculoskeletal infections.
引用
收藏
页码:369 / 377
页数:9
相关论文
共 50 条
  • [21] Complications of Intravesical Bacillus Calmette-Guerin
    Macleod, Liam C.
    Ngo, Tin C.
    Gonzalgo, Mark L.
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2014, 8 (7-8): : E540 - E544
  • [22] Intravesical Bacillus Calmette-Guerin Cystitis
    Ecclestone H.
    Hamid R.
    Current Bladder Dysfunction Reports, 2017, 12 (3) : 207 - 211
  • [23] CANCER AND BCG (BACILLUS CALMETTE-GUERIN)
    RUMI, LS
    ACTA PHYSIOLOGICA LATINOAMERICANA, 1981, 31 (01) : 25 - 34
  • [24] The lipids of the bacillus Calmette-guerin (BCG).
    Chargaff, E
    HOPPE-SEYLERS ZEITSCHRIFT FUR PHYSIOLOGISCHE CHEMIE, 1933, 217 : 115 - 137
  • [25] Infant with bacillus Calmette-Guerin infection
    Ajami, Rasha Isabel Perez
    Duran, Amalia Maria Garcia
    Alonso, Matilde Bustillo
    Bayon, Jesus Maria Vinuelas
    MEDICINA CLINICA, 2024, 162 (11): : e57 - e57
  • [26] Management of Bacillus Calmette-Guerin Lymphadenitis
    Chan, W. M.
    Kwan, Y. W.
    Leung, C. W.
    HONG KONG JOURNAL OF PAEDIATRICS, 2011, 16 (02) : 85 - 94
  • [27] Complications of misuse of Bacillus Calmette-Guerin
    Cevik, Y.
    Ozer, M.
    Das, M.
    Ertok, I
    Kavalci, C.
    Ergul, E.
    Durukan, P.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2011, 112 (06): : 363 - 364
  • [28] Strategies for Optimizing Bacillus Calmette-Guerin
    Shah, Jay B.
    Kamat, Ashish M.
    UROLOGIC CLINICS OF NORTH AMERICA, 2013, 40 (02) : 211 - +
  • [29] COMPLICATIONS OF BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY
    LAMM, DL
    UROLOGIC CLINICS OF NORTH AMERICA, 1992, 19 (03) : 565 - 572
  • [30] BACILLUS CALMETTE-GUERIN (BCG) ENDOPHTHALMITIS
    LESTER, H
    ERDEY, RA
    FASTENBERG, DM
    SCHWARTZ, PL
    ROSENHAUS, JB
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 1988, 8 (03): : 182 - 184